These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11534982)

  • 1. Classical and nonclassical estrogen action in the developing midbrain.
    Küppers E; Ivanova T; Karolczak M; Lazarov N; Föhr K; Beyer C
    Horm Behav; 2001 Sep; 40(2):196-202. PubMed ID: 11534982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and the development and protection of nigrostriatal dopaminergic neurons: concerted action of a multitude of signals, protective molecules, and growth factors.
    Kipp M; Karakaya S; Pawlak J; Araujo-Wright G; Arnold S; Beyer C
    Front Neuroendocrinol; 2006 Dec; 27(4):376-90. PubMed ID: 16949139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type-specificity of nonclassical estrogen signaling in the developing midbrain.
    Beyer C; Ivanova T; Karolczak M; Küppers E
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):319-25. PubMed ID: 12361721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogenic stimulation of neurite growth in midbrain dopaminergic neurons depends on cAMP/protein kinase A signalling.
    Beyer C; Karolczak M
    J Neurosci Res; 2000 Jan; 59(1):107-16. PubMed ID: 10658191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor-alpha is associated with the plasma membrane of astrocytes and coupled to the MAP/Src-kinase pathway.
    Pawlak J; Karolczak M; Krust A; Chambon P; Beyer C
    Glia; 2005 May; 50(3):270-5. PubMed ID: 15712205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
    Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
    Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of gene expression in the developing midbrain by estrogen: implication of classical and nonclassical steroid signaling.
    Beyer C; Pawlak J; Brito V; Karolczak M; Ivanova T; Kuppers E
    Ann N Y Acad Sci; 2003 Dec; 1007():17-28. PubMed ID: 14993036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal striatum- and ventral mesencephalon-derived expanded neurospheres rescue dopaminergic neurons in vitro and the nigro-striatal system in vivo.
    Moses D; Drago J; Teper Y; Gantois I; Finkelstein DI; Horne MK
    Neuroscience; 2008 Jun; 154(2):606-20. PubMed ID: 18472226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen: a multifunctional messenger to nigrostriatal dopaminergic neurons.
    Küppers E; Ivanova T; Karolczak M; Beyer C
    J Neurocytol; 2000; 29(5-6):375-85. PubMed ID: 11424954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unconventional effects of estrogen uncovered.
    Dluzen DE
    Trends Pharmacol Sci; 2005 Oct; 26(10):485-7. PubMed ID: 16122814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bdnf gene is a downstream target of Nurr1 transcription factor in rat midbrain neurons in vitro.
    Volpicelli F; Caiazzo M; Greco D; Consales C; Leone L; Perrone-Capano C; Colucci D'Amato L; di Porzio U
    J Neurochem; 2007 Jul; 102(2):441-53. PubMed ID: 17506860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.
    Simon HH; Bhatt L; Gherbassi D; Sgadó P; Alberí L
    Ann N Y Acad Sci; 2003 Jun; 991():36-47. PubMed ID: 12846972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen signaling in the hypothalamus.
    Kelly MJ; Qiu J; Rønnekleiv OK
    Vitam Horm; 2005; 71():123-45. PubMed ID: 16112267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic networks controlling the development of midbrain dopaminergic neurons.
    Prakash N; Wurst W
    J Physiol; 2006 Sep; 575(Pt 2):403-10. PubMed ID: 16825303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional alterations of the nigrostriatal dopamine system in estrogen receptor-alpha knockout (ERKO) mice.
    Küppers E; Krust A; Chambon P; Beyer C
    Psychoneuroendocrinology; 2008 Jul; 33(6):832-8. PubMed ID: 18472350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling.
    Katsuki H; Kurimoto E; Takemori S; Kurauchi Y; Hisatsune A; Isohama Y; Izumi Y; Kume T; Shudo K; Akaike A
    J Neurochem; 2009 Jul; 110(2):707-18. PubMed ID: 19457078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
    Miller AD; Forster GL; Yeomans JS; Blaha CD
    Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of ovarian steroid signaling in the hypothalamus.
    Rønnekleiv OK; Kelly MJ
    Front Neuroendocrinol; 2005 Sep; 26(2):65-84. PubMed ID: 16009409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental expression of MNAR mRNA in the mouse brain.
    Pawlak J; Beyer C
    Cell Tissue Res; 2005 Jun; 320(3):545-9. PubMed ID: 15846512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-genomic actions of estrogens and their interaction with genomic actions in the brain.
    Vasudevan N; Pfaff DW
    Front Neuroendocrinol; 2008 May; 29(2):238-57. PubMed ID: 18083219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.